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Original Article
Left ventricular blood flow kinetic energy is associated with the 
six-minute walk test and left ventricular remodelling post valvular 
intervention in aortic stenosis
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Background: Left ventricular (LV) kinetic energy (KE) assessment by four-dimensional flow cardiovascular 
magnetic resonance (4D flow CMR) may offer incremental value over routine assessment in aortic stenosis 
(AS). The main objective of this study is to investigate the LV KE in patients with AS before and after the 
valve intervention. In addition, this study aimed to investigate if LV KE offers incremental value for its 
association to the six-minute walk test (6MWT) or LV remodelling post-intervention. 
Methods: We recruited 18 patients with severe AS. All patients underwent transthoracic echocardiography 
for mean pressure gradient (mPG), CMR including 4D flow and 6MWT. Patients were invited for post-valve 
intervention follow-up CMR at 3 months and twelve patients returned for follow-up CMR. KE assessment 
of LV blood flow and the components (direct, delayed, retained and residual) were carried out for all cases. 
LV KE parameters were normalised to LV end-diastolic volume (LVEDV).
Results: For LV blood flow KE assessment, the metrics including time delay (TD) for peak E-wave from 
base to mid-ventricle (14±48 vs. 2.5±9.75 ms, P=0.04), direct (4.91±5.07 vs. 1.86±1.72 μJ, P=0.01) and 
delayed (2.46±3.13 vs. 1.38±1.15 μJ, P=0.03) components of LV blood flow demonstrated a significant change 
between pre- and post-valve intervention. Only LV KEiEDV (r=−0.53, P<0.01), diastolic KEiEDV (r=−0.53, 
P<0.01) and Ewave KEiEDV (r=−0.38, P=0.04) demonstrated association to the 6MWT. However, Pre-operative 
LV KEiEDV (r=0.67, P=0.02) demonstrated association to LV remodelling post valve intervention. 
Conclusions: LV blood flow KE is associated with 6MWT and LV remodelling in patients with AS. LV 
KE assessment provides incremental value over routine LV function and pressure gradient (PG) assessment 
in AS.
Keywords: Aortic valve stenosis; walk test; ventricular remodeling; exercise tolerance; echocardiography; Doppler; 
magnetic resonance imaging; 4D flow
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Introduction 
Aortic stenosis (AS) is the third most common cardiovascular 
disease in Western countries and the commonest valvular 
disease requiring valve replacement (1,2). Management of 
patients with AS depends on understanding the criteria for 
the assessment of the severity of the disease. According 
to the current European Society of Cardiology (ESC) or 
the European Association for Cardio-Thoracic Surgery 
(EACTS) guidelines, the indications for aortic valve 
replacement depend on the patient’s symptoms and the 
severity of the stenosis (3). It is often debated which 
treatment option should be offered to yield optimum 
results. Therefore, appropriate diagnosis and classification 
of the disease severity are crucial for the management 
of AS. The haemodynamic effects of AS have significant 
implications on left ventricular (LV) remodelling (4). 
Although the main haemodynamic effect in AS is an 
increase in afterload due to the increased outflow resistance. 
However, preload is also affected as a consequence of LV 
compliance reduction (5). Thus, LV remodelling plays an 
important role in the clinical symptoms and leads to the 
development of heart failure in AS (4,5).
Recent studies on novel biomarkers in AS have 
demonstrated the role of multi-parametric t issue 
characterisation by cardiovascular magnetic resonance 
(CMR) imaging (6-10). In the diastolic cascade, reduction 
in LV compliance results in raised LV filling pressure 
which in turn affects the trans-mitral or LV intra-cavity 
flow immediately (11). Subsequently, adverse myocardial 
remodelling will ensue. Hence, the assessment of LV blood 
flow using kinetic energy (KE) as a modality may offer a 
unique opportunity to detect early deterioration in AS.
LV intra-cavity blood flow KE (LV KE) assessment 
by four-dimensional flow (4D flow) CMR has been 
demonstrated to be superior to mitral inflow for its 
association to LV diastolic function (11). In addition, LV 
KE assessment can detect early changes in blood flow 
in myocardial infarct patients with preserved ejection 
fraction (12). 
However, it remains unknown how the LV blood flow 
KE adapts to severe AS and also what happens to it after 
the reduction of afterload following valve intervention. The 
diagnostic value of this needs to be determined. Therefore, 
the main objectives of this study are: (I) to investigate 
the LV KE in patients with AS before and after the valve 
intervention, (II) to investigate if the KE of the blood flow 
components can provide an insight into the haemodynamic 
of AS, and finally, to study if LV KE in patients with AS is 
associated with quantitative physical endurance evaluated by 
the six-minute walk test (6MWT).
Methods
Study population
This study was a sub-study of the EurValve project (http://
www.eurvalve.eu/). We prospectively recruited 18 patients 
diagnosed with severe AS by echocardiography. All patients 
with severe AS and in need of valve intervention at our centre 
between 2017 and 2018 were eligible for this study. Patients 
with significant disease of other valves or aortic regurgitation 
were excluded. We also excluded patients with coronary artery 
disease (CAD) requiring coronary artery bypass grafting 
surgery (CABG), acute myocardial infarction or needing 
any coronary intervention, limited imaging data, any MRI 
contraindications or the inability to complete a 6MWT.
CMR examination 
All patients underwent CMR examination to acquire 
morphological images and 4D flow data. The 4D flow 
data were obtained during free-breathing, using an 
ECG-triggered, retrospectively navigator-gated, three-
dimensional, three-directional, time-resolved phase-
contrast MRI sequence on a clinical 3T system (Ingenia, 
Philips Healthcare, Best, The Netherlands).
CMR protocol and data acquisition
The CMR protocol included complete short-axis cines 
covering the whole left ventricle for each acquisition, 3 sets 
of long-axis cines (two-, three-, and four-chamber), and 
3-directional phase-contrast velocity images. Single heartbeat 
was divided into 20 time-steps to form the cine images. 
The number of slices varied according to the size of each 
patient’s heart. Scan parameters for cines images included: 
SENSE with a speed-up factor of 2–3, flip angle 45°, echo 
time (TE) 1.5 ms, repetition time (TR) 3.05 ms, spatial 
resolution of 2.5×2.5 mm2, pixel size of 1.56×1.56 mm2, 
field of view (FOV) 400 mm, and a slice thickness of 
6.0 mm with contiguous slices for the short axis stack. 
4D flow acquisition
Scan parameters for 4D flow acquisitions included: acquired 
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spatial resolution of 3×3×3 mm3, TR 10.7 ms, TE 3.5 ms 
and a reconstructed voxel size of 1.5×1.5×15 mm3. Other 
acquisition scan parameters of this sequence were: flip angle 
10°, an approximate FOV of 340 mm × 340 mm, no slice 
gap, and k-space segmentation factor of 3. The number of 
signal averages was 1, with 30 cardiac phases. Previously 
validated echo-planar acceleration (EPI) with a shot factor 
of 5 was applied (13). The velocity encoding (VENC) was 
obtained from echocardiographic images to reduce scan 
time and optimised if aliasing occurred, 150 cm/s was used 
as a starting point and adjusted accordingly. These settings 
gave a temporal resolution of 40 ms. After data acquisition, 
the 4D flow data was reconstructed into 30-time frames on 
the scanner. 
4D flow corrections 
Data pre-processing was done on the scanner for correcting 
phase offset errors such as eddy currents, Maxwell effects, 
and encoding errors related to gradient field distortions to 
avoid impairment of the measurements and inaccuracies in 
flow quantification (14,15).
Image analysis
All images were post-processed and analysed using a 
previously validated method (12,16). Manual contouring 
of the endocardial and epicardial surfaces, excluding the 
papillary muscles, was performed on the stack of short-axis 
cine images to obtain LV end-diastolic volume (LVEDV) 
and LV end-systolic volume (LVESV) in Mass software 
(Version 2019 EXP, Leiden University Medical Centre, 
Leiden, The Netherlands). From end-diastolic (ED) and 
end-systolic (ES) volumes, LV stroke volume (LVSV) and 
LV ejection fraction (LVEF) were calculated. Ventricular 
mass was calculated at end-diastole; the interventricular 
septum was considered part of the LV (17). During systolic 
phases, cautious segmentation of only those basal segments 
was done where there was evidence of myocardium and this 
was also confirmed in long-axis cines—both four-chamber 
and two-chamber cines. 
The KE of each voxel of blood was computed using the 
following formula: 
blood voxel voxel
KE 1/ 2ρ V v 2×= ×  [1]
Where the ρblood represents the density of blood (1.06 g/cm3), 
V voxel represents the voxel volume, and v represents the 
velocity magnitude. The total LV KE was then computed 
in each time step as the summation of the KE of all voxels 
in the left ventricle and plotted by the software as a time-
resolved KE curve where different KE parameters were 
derived from this curve. All KE parameters were normalized 
to LV EDV and reported in μJ/mL (LV KEiEDV) (Figure 1).
LV blood flow component analysis
We applied a previously validated technique which enables 
the separation of the LV ED flow into four different 
functional components (18). LV short-axis cine stack, long-
axis cine, and 4D flow images views were used for the 
analysis. The short-axis cine series was used to define the 
intraventricular blood particles. LV endocardial contours 
were manually traced in the ES and ED phases. The most 
basal short-axis slice in ES was used as inflow/outflow plane 
and particles were considered as invalid when they were 
either below the inflow/outflow plane or outside the LV 
epicardial contours in ES phase. 
The ED blood flow was divided into four functional flow 
components, according to the transit of blood flow through 
the LV chamber for the complete cardiac cycle: (I) direct 
flow is the volume of the blood that enters the LV and 
ejected during the same cardiac cycle, (II) delayed ejection 
flow is the volume of the ejected blood that enters the left 
ventricle from a previous cardiac cycle, (III) retained inflow 
is the volume of the blood that enters the left ventricle 
but does not eject in the same cardiac cycle, and (IV) the 
residual volume is the blood that resides in the LV over the 
entire cardiac cycle for at least 2 cardiac cycles. The results 
of particle tracing were reviewed visually and data quality 
was checked as previously described (18). After the quality 
was thoroughly assessed, the KE of the volume of each flow 
components were calculated over a complete cardiac cycle.
6MWT 
6MWT was performed before and after the intervention 
according to the protocol based on the guidelines 
established by the American Thoracic Society (19). 
Statistical analysis
Statistical analysis was carried out with IBM SPSS® 
Statistics (Version 25) software. All data were treated as 
non-parametric. Continuous measurements are presented 
as median with interquartile ranges (IQR). A paired 
nonparametric two-tailed test (Wilcoxon signed-rank test) 
was used for paired analysis. Mann-Whitney test was used 
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for all continuous variables to compare differences between 
two different procedure options of the aortic valve. For 
investigating associations between two categorical variables, 
non-parametric Chi-squared test (χ2) was used (20). 
Correlation between variables was assessed by Spearman 
correlation coefficient (rho), Value of P<0.05 was considered 




The demographic data of the patients were fully summarized 
in (Table 1). Eighteen patients completed the full study 
protocol with a mean age of 74.6, ranging from 53 to 
89 years. Ten patients underwent SAVR whereas eight 
patients underwent TAVI procedure. SAVR patients were 
younger than TAVI patients (68±8 vs. 82±11 years old, 
P=0.01), and the 6MWT was better in SAVR patients as 
compared to TAVI cohort (409±182 vs. 318±96.5 meters, 
P=0.02). From 18 patients recruited, 6 were in atrial 
fibrillation (AF) (Table S1). Patients in AF had lower LVSV. 
On direct comparison, the heart rate (HR) was comparable 
in patients with AF versus in patients with sinus rhythm. 
Only one patient had a bicuspid aortic valve. A total of 
6 post-operative patients including 1 SAVR and 5 TAVI 
declined to come back for research CMR scan. 4D flow 
CMR scans were performed between 2017 and 2018 at a 
mean time of 3 months before and after the intervention.
Paired comparison of pre- and post-operative data changes
Haemodynamic parameters
There were no significant changes in the systolic blood 
pressure and diastolic blood pressure or the HR after the 
valve intervention (P=0.41, P=0.83, P=1.0 respectively). 
The transthoracic echocardiographic haemodynamic 
Figure 1 Case example from our study. The top panel demonstrates LV blood flow KE assessment. Even though the pattern was different 
for systolic and diastolic KE curves after intervention, the average quantified values for not significantly different. The second panel 
demonstrates a three-chamber image with superimposed particle tracing component analysis of the four LV blood flow components: 
retained inflow (yellow), residual volume (red), direct flow (green), and delayed ejection flow (blue). It is worth noting that the drop in direct 
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measurement showed a significant reduction in the mean 
pressure gradient (PG) (P=0.001) (Figure 2). LVEDV, LV 
SV, and LV mass were decreased significantly after the 
valve intervention (P=0.02, P=0.009, P=0.002 respectively), 
however, there were no significant changes in both LVESV 
and EF (P=0.09, P=0.38 respectively) (Table 2). 
KE parameters
Table 2 provides a full summary of LV KEiEDV parameters 
before and after the intervention. The results from 
Wilcoxon analysis demonstrated that pre and post aortic 
valve interventions (SAVR/TAVI), average LV KEiEDV 
(12.0±3.4 vs. 11.2±4.6 μJ/mL), average systolic LV KEiEDV 
(10.3±3.8 vs. 11.8±5.0 μJ/mL), and average diastolic LV 
KEiEDV (12.5±2.9 vs. 11.8±6.3 μJ/mL), were comparable 
(P=0.52, P=0.85, P=0.27 respectively). Furthermore, there 
were no significant changes in the early and late diastolic (E 
and A waves) peaks (P=0.38, P=0.91 respectively).
The relative drop in mitral flow KE parameters (from 
base to mid-ventricle and from mid-ventricle to apex) were 
also not changed significantly after the valve intervention 
(P=0.27, P=0.15). 
Early diastolic time delay (TD)
Figure 2 shows the change of TD and some CMR functional 
parameters before and after the intervention for all the 
patients. The delayed time for the travel of the blood from 
the base to mid-ventricle during the early diastolic phase 
(TD) was significantly decreased after the valve procedure 
(14±48 vs. 2.5±9.75 msec, P=0.04) (Table 2). 
Table 1 Study demographics
Variables All patients (n=18) Chosen for TAVI (n=8) Chosen for SAVR (n=10) P
Age (years) 74 [16] 82 [11] 68 [8] 0.01
Gender (female) 14 (78%) 8 (100%) 6 (60%) 0.05
BMI (kg/m²) 27.7 [7.5] 23.3 [9.7] 28.1 [4.4] 0.32
Systolic BP (mmHg) 152 [18.2] 150.5 [1] 156.5 [25] 0.63
Diastolic BP (mmHg) 75 [15] 70 [15] 76 [14] 0.45
HR (bpm) 64 [11] 63 [11] 65 [11] 0.94
IHD 1 (6%) 1 (12%) 0 (0%) 0.26
DM 4 (22%) 2 (25%) 2 (20%) 0.81
Hypertension 12 (67%) 7 (87%) 5 (50%) 0.10
ARB blocker 1 (6%) 0 (0%) 1 (10%) 0.37
ACEi 3 (17%) 2 (25%) 1 (10%) 0.41
Beta-blocker 4 (22%) 2 (25%) 2 (20%) 0.81
Ca channel blocker 6 (33%) 3 (37%) 3 (30%) 0.74
Loop diuretics 4 (22 %) 3 (37 %) 1 (10%) 0.18
Mean TTE PG (mmHg) 34 [14] 40 [11] 32 [8] 0.22
Peak TTE PG (mmHg) 70 [22] 77 [28] 64 [22] 0.12
EOA (cm
2
) 0.7 [0.36] 0.54 [0.21] 0.83 [0.35] 0.03
6MWT (m) 357.5 [103] 318 [96.5] 409 [182] 0.02
NYHA 2 [0] 2 [1] 2 [0] 0.46
The data are shown as median [IQR], or n (%). For all continuous variables, P value was done using the Mann-Whitney test. For all 
categorical variables, P value was calculated using the chi-squared test. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin 
II receptor blockers; BMI, body mass index; BP, blood pressure; Ca, calcium; DM, diabetes mellitus; HR, heart rate; IHD, ischemic heart 
disease; NYHA, New York Heart Association classification; PG, pressure gradient; TTE, transthoracic echocardiogram; 6MWT, 6-minute 
walk test.
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Flow components analysis
The volume and distribution of the LV flow components 
were determined in all patients before and after the 
intervention. The calculated volumes of LV inflow and 
outflow were well matched (concordance correlation 
coefficient =0.91, 95% confidence interval, 0.83 to 0.96, 
P<0.0001; mean bias =−0.82, 95% confidence interval −3.5 
to 1.9, P=0.55; 41.76±17.69 vs. 42.11±18.07 mL, P=0.59). 
The Wilcoxon analysis of the blood component KE reveals 
that the KE of both direct flow and delayed flow was 
significantly reduced after the intervention (P=0.01, P=0.04 
respectively) (Table 2), whereas no significant changes were 
noted for the LV KE of the other two components (Table 2).
Association with 6MWT
There were no significant differences in the preoperative 
versus postoperative 6MWT (373±96.6 vs. 360±146 meters, 
P=0.76). The results from the non-parametric Spearman’s 
analysis revealed that there was a significant negative 
correlation between 6MWT and the average LV KEiEDV 
(r=−0.53, P=0.003), average diastolic KEiEDV (r=−0.53, 
P=0.003), and peak E-wave KEiEDV (r=−0.38, P=0.04) 
(Figure 3). 6MWT correlated positively with the relative 
drop in mitral flow KEiEDV (r=0.40, P=0.033). However, 
there was no correlation observed with the other LV KEiEDV 
parameters. Interestingly, 6MWT did not correlate with 
KE of the four blood components (Table 3) respectively. 
There was positive correlation between 6MWT and both 
LVEDV, SV (r=0.36, P=0.05; r=0.36, P=0.05 respectively), 
however, LVESV, LV mass, and EF did not show any 
significant correlation with 6MWT (P=0.18, P=0.49, P=0.22 
respectively) (Table 3).
Association with NYHA classification
There was no significant association between the imaging 
parameters and the patient’s symptoms assessed by NYHA 
classification (Table 3).
Association with LV remodelling
From the LV KE parameters, only the preoperative average 
KEiEDV was significantly correlated with the absolute 
change in LV mass post-operatively (P=0.02) (Table 4 and 
Table S2). Preoperative routine assessment (LV EF and 
mean TTE PG) did not show any significant changes with 
LV remodelling in the post-operative phase (P=0.25, P=0.73 
respectively) (Figure 4).
Figure 2 Pre and post aortic valve intervention box and whisker charts demonstrating a significant drop in LV mass and the associated drop 
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Discussion
To our knowledge, this is the first study to report the LV 
blood flow KE in patients with AS—both in pre and post 
valvular intervention stages. In addition, this study gives 
mechanistic insight into changes associated with AS in 
the assessment of KE of the blood flow component. The 
main findings of this study include that the average KE of 
the blood flow through the left ventricle does not change 
significantly following valve intervention. However, the 
TD, direct flow and delayed flow are significantly altered 
post valvular intervention. In addition, LV blood flow KE 
metrics demonstrated best association with the 6MWT. 
Finally, LV remodelling at 3-months was only associated 
with the delayed flow component of LV flow. 
LV KE before and after the intervention
The results from our study reveal that the LV blood flow 
KE does not change significantly after valve intervention 
and thus remains preserved. This was an unexpected 
finding—however, we speculate that this is the result of 
energy preservation of blood flow coupled with left ventricle 
mechanics. However, different components of blood flow 
KE demonstrated changes in pre valve intervention to post 
valve intervention cohort. Both direct and delayed flow 
components KE were significantly reduced post valvular 
intervention. It is worth noting that the rise in direct and 
delayed flow components in severe AS patients was mainly 
observed in late diastolic filling phase (Figure 1). However, 
further research is warranted to explain this phenomenon. 
In our study, LV blood flow KE demonstrated inverse 
correlation to the quantitative physical endurance, i.e., 
the 6MWT. This was not seen for standard CMR derived 
functional and volumetric assessment. Several studies have 
reported that the 6MWT is a reliable measure of the overall 
impact of a clinical condition and a predictor of increased 
mortality (21-23). Hence, an increase in the LV blood 
flow KE may provide a novel haemodynamic biomarker of 
Table 2 Paired comparison of pre- and post-operative changes in cardiac haemodynamics, imaging parameters and functional parameters at  
3 months (n=12)
Variables Pre-op (severe AS), median [IQR] Post-op (TAVI/SAVR), median [IQR] P*
LVEDV (mL) 128 [55] 125 [54] 0.02
LVESV (mL) 46 [45] 52 [39] 0.09
LV SV (mL) 84 [15] 76.3 [19] 0.01
LV mass (g) 139.6 [76] 97.9 [64] <0.01
LV EF (%) 59 [19] 61.4 [13] 0.38
LV blood flow kinetic energy assessment
Average KEiEDV (μJ/mL) 12 [3.4] 11.2 [4.6] 0.52
Average systolic KEiEDV (μJ/mL) 10.3 [4] 11.8 [5] 0.85
Average diastolic KEiEDV (μJ/mL) 12.5 [2.9] 11.8 [6.3] 0.27
Peak E-wave KEiEDV (μJ/mL) 23.9 [22.1] 21.6 [10] 0.38
Peak A-wave KEiEDV (μJ/mL) 17 [19.2] 18.1 [13.6] 0.91
TD for peak E-wave (ms) 14 [48] 2.5 [9.7] 0.04
LV blood flow component specific kinetic energy assessment
Direct KE (μJ) 4.9 [5] 1.86 [1.7] 0.01
Delayed KE (μJ) 2.46 [3] 1.38 [1] 0.03
Retained KE (μJ) 1.07 [0.8] 0.91 [0.9] 0.85
Residual KE (μJ) 0.84 [1.4] 0.98 [0.8] 0.79
*, Wilcoxon test (paired samples). KE, kinetic energy; KEiEDV, kinetic energy indexed for LV end-diastolic volume; LV, left ventricular; LVEDV, 
left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; SV, stroke volume; EF, ejection fraction; TD, time delay.
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physical endurance that could be a useful early parameter in 
the assessment of function, morbidity and perhaps prognosis 
in patients with AS. However, previous studies from our 
group have demonstrated that the average LV blood flow 
KE has a trend to reduce slightly with age, hence the 
association with 6MWT may become more relevant when 
a patient develops AS and requires longitudinal monitoring 
of progress. Future studies should evaluate clinical cut-offs 
which predict outcomes in AS. 
It was worth noting that none of the non-invasive 
functional or haemodynamic parameters demonstrated 
association to NYHA functional class. While it is tempting 
to blame this on the subjectivity of NYHA functional class 
and to claim that it may have a limited role in precision 
medicine. However, we need to admit that NYHA class 
withstood the test of time since 1923 and remains broadly 
a reliable classification in making therapeutic decisions in 
cardiology. 
Early diastolic TD 
Normally, the blood flows rapidly into the LV cavity 
from the base to the apex of the heart. In this study, we 
measured the TD described before by our research group 
as a marker of LV compliance and diastolic function 
(12,16). TD increases in patients who had an MI with 
preserved LVEF and also has a diagnostic value in patients 
with LV thrombus. The significant reduction in TD 
reflects an improvement in restrictive LV filling after the 
valve intervention. This method is similar to the assessment 
Figure 3 Scatter-matrix demonstrating data distribution for 6MWT and its association to LV blood flow KE in the whole study population 
both pre- and post-valvular intervention. 6MWT, six-minute walk test; LV, left ventricle; KE, kinetic energy; TD, time delay.
Pre-operative severe AS
Post SAVR/TAVI
0    190  380  570  760  0.0  7.8  15.6  23.4       0      11     22    33           0     12    24    36        0     41      82   123       0     27    54    81  −60    0     60    120
1478 Elhawaz et al. 4D f low CMR derived LV blood f low KE in aortic stenosis
© Quantitative Imaging in Medicine and Surgery. All rights reserved.   Quant Imaging Med Surg 2021;11(4):1470-1482 | http://dx.doi.org/10.21037/qims-20-586
of the mitral valve flow propagation velocity (Vp) by 
echocardiography, which is normally more than 50 cm/sec (24). 
However, the TD here is derived automatically using 3D 
flow quantified data versus VP which is very susceptible to 
operator variability (25,26).
Predictors of positive LV remodelling 
The on ly  pre-opera t i ve  CMR parameter  wh ich 
demonstrated good association to LV remodelling post 
valve intervention was average LV blood flow KEiEDV for 
the complete cardiac cycle. Both PG by echocardiography 
and CMR LVEF did not demonstrate any added value 
for prediction. In this small pilot study, peak Ewave KEiEDV 
showed a trend towards association with LV remodelling. This 
is consistent with previous CMR study which demonstrated no 
added predictive value of routine PG and function assessment 
for LV remodelling in patients with AS (21,22).
Relation to earlier studies
Although this study did not recruit healthy control, patients 




R* P R* P
Haemodynamic parameters
BP systolic (mmHg) 0.08 0.67 0.23 0.20
BP diastolic (mmHg) 0.18 0.34 0.26 0.14
HR (bpm) –0.02 0.92 –0.27 0.22
CMR functional parameters
LVEDV (mL) 0.15 0.45 0.36 0.05
LVESV (mL) 0.13 0.52 0.24 0.19
LV mass (g) 0.33 0.08 0.13 0.49
LV SV (mL) 0.14 0.46 0.36 0.05
LV EF (%) –0.10 0.60 –0.23 0.22
Left ventricular kinetic energy assessment
Average KEiEDV (μJ/mL) 0.05 0.82 –0.53 <0.01
Average systolic KEiEDV (μJ/mL) –0.07 0.71 –0.31 0.09
Average diastolic KEiEDV (μJ/mL) 0.06 0.77 –0.53 <0.01
Peak E-wave KEiEDV (μJ/mL) 0.15 0.44 –0.38 0.04
Peak A-wave KEiEDV (μJ/mL) –0.22 0.25 –0.20 0.29
TD for peak E-wave (Base→mid) (ms) 0.21 0.28 0.02 0.94
The kinetic energy of LV blood flow components
Direct flow KE (μJ) 0.25 0.23 –0.02 0.94
Delayed flow KE (μJ) 0.17 0.42 –0.09 0.64
Residual flow KE (μJ) 0.01 0.96 0.06 0.77
Retained flow KE (μJ) –0.35 0.09 –0.16 0.43
*, Spearman’s rho correlation coefficient. BP, blood pressure; HR, heart rate; KE, kinetic energy; LV, left ventricular; LVEDV, left ventricular 
end-diastolic volume; LVESV, left ventricular end-systolic volume; SV, stroke volume; EF, ejection fraction; NYHA, New York Heart 
Association classification; TD, time delay; 6MWT, 6-minute walk test.
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Table 4 Correlation of LV mass change pre-/post aortic valve replacement to imaging parameters
Pre-operative CMR metrics
Absolute change in LV mass post-operatively
R* P
Routine assessment
LV EF (%) 0.36 0.25
Mean TTE PG (mmHg) 0.11 0.73
LV blood flow kinetic energy
Average KEiEDV 0.67 0.02
Average systolic KEiEDV 0.5 0.1
Average diastolic KEiEDV 0.22 0.5
Peak E-wave KEiEDV 0.56 0.06
Peak A-wave KEiEDV 0.03 0.93
TD for peak E-wave (base→mid) –0.53 0.07
The kinetic energy of LV blood flow components
Direct flow KE –0.26 0.43
Delayed flow KE –0.44 0.18
Retained flow KE –0.23 0.5
Residual flow KE 0.07 0.83
*, Spearman’s rho correlation coefficient. KE, kinetic energy; LV, left ventricular; EF, ejection fraction; PG, pressure gradient; TD, time delay; 
TTE, transthoracic echocardiogram.
with AS appear to have higher LV KE when compared to 
similar age group patients in previous studies (12.0±3.4 vs. 
8±1.3 μJ/mL) (23). This could be explained by the increased 
outflow tract velocity in this cohort. Also, the diastolic and 
peak E-wave KE were higher in this study when compared 
to Crandon et al.’s work, and may reflect higher degree 
of deterioration of LV compliance in AS patients than 
previously studied healthy controls. 
Clinical implications and future direction 
This study demonstrates the feasibility of three-dimensional 
quantification of blood flow in the LV cavity from the 
complete cardiac cycle in patients with AS. The results 
from this pilot work are hypothesis generating and the 
real clinical value of LV blood flow KE needs to be tested 
in a larger clinical cohort. From this study, it would seem 
that LV blood flow KE may offer novel imaging flow-
based based biomarkers which reflect the true functional 
status of the patient quantified by the 6MWT. The LV 
blood flow KE assessment may also have a prognostic 
role in understanding of LV remodelling post aortic valve 
intervention. However, as there is emerging evidence of 
multi-parametric CMR including tissue characterisation 
in AS assessment, the overall clinical role of LV blood flow 
KE assessment may only be complimentary. Nevertheless, 
this is likely to make CMR a more versatile tool for a 
comprehensive assessment of AS. 
Limitations and further works
This study has some limitations. Because of small numbers 
of patients recruited to this study, findings are mainly 
hypothesis-generating. Future larger sample sizes with 
long-term studies are required to detect possible changes 
in intra-ventricular blood flow behaviour over a complete 
cardiac cycle, and potential differences according to the 
surgical approach. In addition, a direct age-matched 
comparison with healthy volunteers was not done in this 
study. Furthermore, assessment of the difference in LV 
KE profiles between the two different treatment options 
of the aortic valve replacement (TAVI and SAVR) would 
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Figure 4 Scatter matrix demonstrating an association of LV remodelling post SAVR/TAVI is associated with pre-intervention LV blood 
flow KE only and not with LV EF or AV mPG. LV, left ventricle; KE, kinetic energy; SAVR, surgical aortic valve replacement; TAVI, 
transcatheter aortic valve implantation; EF, Ejection fraction; AV, aortic valve; mPG, mean pressure gradient.
be interesting to study. Higher VENC settings in pre-
operative cases may have introduced noise in lower velocity 
profiles, which could influence our results. 
Conclusions
LV blood flow KE is associated with 6MWT and LV 
remodelling in patients with AS. LV KE assessment 
demonstrates complimentary value to routine LV function 
and PG assessment in AS. Future prognostic and larger 
clinical studies are warranted to establish the cumulative 
role of routine LV blood flow KE assessment in patients 
with AS. 
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Table S1 Comparison of patients in atrial fibrillation with patients in sinus rhythm. 
Variable Sinus rhythm (n=12), median [IQR] Atrial fibrillation (n=6), median [IQR] P
Heart rate (bpm) 63 [20] 71 [22] 0.12
LVEDV (mL) 128 [55] 115 [70] 0.34
LVESV (mL) 46 [39] 47 [43] 0.75
LV SV (mL) 85 [17] 68 [22] 0.03
LV EF (%) 59 [18] 59 [15] 0.82
LV mass (g) 140 [60] 122 [90] 0.44
NYHA 2 [0] 3 [1] 0.26
6MWT 339 [113] 378 [115] 0.96
Average KEiEDV 13 [6] 12 [11] 0.82
Average systolic KEiEDV 12 [7] 9 [6] 0.49
Average diastolic KEiEDV 13 [8] 16 [18] 0.15
Peak E-wave KEiEDV 23 [24] 36 [28] 0.08
Peak A-wave* KEiEDV 27 [23] – –
*, peak A-wave KEiEDV cannot be compared as in AF it is not recorded. 
Table S2 Linear regression results between absolute LV mass 




Coefficient of determination R
2
0.37
Residual standard deviation 18.8
Regression equation y =−86.7155+4.4940x
Parameter Coefficient
Intercept −86.7155
Slope 4.494
Analysis of variance
Source DF
Regression 1
Residual 10
F-ratio 5.9933
Significance level P=0.03
Supplementary
